New Injectable Asthma Medicine
Asthma is the number one killer diseases around the world. Around 300 million people around the world have this diseases. After long research the steroid based inhaler was first introduced by world's top ranking medicine company GlaxoSmithKline in 1969. It was introduced first as a ventolin inhaler.
Inhaler helps to clean airways to transmit air into lung. When people get severe attack of asthma then inhaler is the only one medicine who can reliefs people from killer diseases asthma. It is passing around 45 years. No developed medicine is created yet to treat asthma. But it is a great news that new inject-able asthma medicine is invented by the medicine company GlaxoSmithKline.
The new medicine called IL-5 have tested already on doctors. It got good result. It is still waiting to get regulatory permission. But the problem is that it would not arrive to common people soon. Because of its price. Yearly cost is $15000.
However it is expected the price will be down when its rival likes Roche, AstraZeneca,Teva.and Sanofi will come ahead to compete to produce this new ashtma medicine. Read more from Reuters.
To read asthma triggers you may go here
Asthma is the number one killer diseases around the world. Around 300 million people around the world have this diseases. After long research the steroid based inhaler was first introduced by world's top ranking medicine company GlaxoSmithKline in 1969. It was introduced first as a ventolin inhaler.
Inhaler helps to clean airways to transmit air into lung. When people get severe attack of asthma then inhaler is the only one medicine who can reliefs people from killer diseases asthma. It is passing around 45 years. No developed medicine is created yet to treat asthma. But it is a great news that new inject-able asthma medicine is invented by the medicine company GlaxoSmithKline.
The new medicine called IL-5 have tested already on doctors. It got good result. It is still waiting to get regulatory permission. But the problem is that it would not arrive to common people soon. Because of its price. Yearly cost is $15000.
However it is expected the price will be down when its rival likes Roche, AstraZeneca,Teva.and Sanofi will come ahead to compete to produce this new ashtma medicine. Read more from Reuters.
To read asthma triggers you may go here